APA

Biermann M., Pixberg M. K., Dörr U., Dietlein M., Schlemmer H., Grimm J., Zajic T., Nestle U., Ladner S., Sepehr-Rezai S., Rosenbaum S., Puskás C., Fostitsch P., Heinecke A., Schuck A., Willich N., Schmid K. W., Dralle H. & Schober O. (20060214). Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. : Nuklearmedizin. Nuclear medicine.

Chicago

Biermann M, Pixberg M K, Dörr U, Dietlein M, Schlemmer H, Grimm J, Zajic T, Nestle U, Ladner S, Sepehr-Rezai S, Rosenbaum S, Puskás C, Fostitsch P, Heinecke A, Schuck A, Willich N, Schmid K W, Dralle H and Schober O. 20060214. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. : Nuklearmedizin. Nuclear medicine.

Harvard

Biermann M., Pixberg M. K., Dörr U., Dietlein M., Schlemmer H., Grimm J., Zajic T., Nestle U., Ladner S., Sepehr-Rezai S., Rosenbaum S., Puskás C., Fostitsch P., Heinecke A., Schuck A., Willich N., Schmid K. W., Dralle H. and Schober O. (20060214). Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. : Nuklearmedizin. Nuclear medicine.

MLA

Biermann M, Pixberg M K, Dörr U, Dietlein M, Schlemmer H, Grimm J, Zajic T, Nestle U, Ladner S, Sepehr-Rezai S, Rosenbaum S, Puskás C, Fostitsch P, Heinecke A, Schuck A, Willich N, Schmid K W, Dralle H and Schober O. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice. : Nuklearmedizin. Nuclear medicine. 20060214.